TABLE 1.
Demographic Characteristics of Study Subjects According to Study Drug Assignment
| Overall | Cephalexin Arm | Clindamycin Arm | P | |
|---|---|---|---|---|
| Total no. of subjects | 200 | 100 | 100 | NA |
| Prior skin infections | 69 | 36 | 33 | .61 |
| Location of enrollment | .55 | |||
| ED | 188 | 95 | 93 | |
| Clinic | 12 | 5 | 7 | |
| Black | 188 | 92 | 96 | .23 |
| Age | .82 | |||
| 6–12 mo | 18 | 9 | 9 | |
| 1–5 y | 75 | 35 | 40 | |
| 6–12 y | 45 | 22 | 23 | |
| 13–18 y | 62 | 34 | 28 | |
| Female gender | 115 | 55 | 60 | .47 |
| History of asthma | 58 | 25 | 33 | .21 |
| History of eczema | 68 | 33 | 35 | .77 |
| Antibiotic use ≤6 mo | 49 | 28 | 21 | .25 |
| Underlying CMC | 19 | 10 | 9 | .81 |
| Hospitalization in previous year | 14 | 4 | 10 | .10 |
NA indicates not applicable; CMC, chronic medical condition.